GlassScriptPhysician profile
Annie D Yang
NPI 1962069849
$1,203.65
in general payments reported to CMS, 2019-2025
13 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $139 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $357.05 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $164.20 | 2025 | Wainua |
| Takeda Pharmaceuticals U.S.A., INC. | $157.27 | 2025 | Hyqvia |
| Regeneron Healthcare Solutions, INC. | $114.15 | 2024 | Eylea Hd |
| Biogen, INC. | $103.34 | 2025 | Leqembi |
| Eisai INC. | $81.03 | 2025 | |
| Argenx US, INC. | $67.01 | 2025 | Vyvgart Hytrulo |
| Neurelis, INC. | $44.19 | 2025 | Valtoco |
| Lundbeck LLC | $31.69 | 2025 | Vyepti |
| Inspire Medical Systems, INC. | $24.74 | 2024 | Inspire |
| Lilly USA, LLC | $22.30 | 2025 | Amyvid, Kisunla |
| Tanabe Pharma America, INC. | $20.58 | 2025 | Radicava |
| Celgene Corporation | $16.10 | 2025 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.